Corrigan Financial, Inc. Johnson & Johnson Transaction History

Corrigan Financial, Inc.

$392 Billion
Q2 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 01, 2023	SELL	$154.35 - $166.11 $7,408 - $7,973	-48 Reduced 1.06%	4,484 $742 Million
Q1 2023 Sep 01, 2023	SELL	$151.05 - $180.26 $15,256 - $18,206	-101 Reduced 2.18%	4,532 $703 Million
Q4 2022 Sep 01, 2023	SELL	$160.2 - $179.79 $168,210 - $188,779	-1,050 Reduced 18.48%	4,633 $818 Million
Q3 2022 Sep 01, 2023	BUY	$161.33 - $179.52 $16,455 - $18,311	102 Added 1.83%	5,683 $928 Million
Q2 2022 Sep 01, 2023	SELL	$168.19 - $186.01 $300,050 - $331,841	-1,784 Reduced 24.22%	5,581 $991 Million
Q1 2022 Sep 01, 2023	BUY	$158.14 - $179.59 $302,205 - $343,196	1,911 Added 35.04%	7,365 $1.31 Billion
Q4 2021 Sep 01, 2023	BUY	$155.93 - $173.01 $4,989 - $5,536	32 Added 0.59%	5,454 $933 Million
Q3 2021 Sep 01, 2023	SELL	$161.5 - $179.47 $70,252 - $78,069	-435 Reduced 7.43%	5,422 $876 Million
Q2 2021 Sep 01, 2023	SELL	$159.48 - $171.07 $9,568 - $10,264	-60 Reduced 1.01%	5,857 $965 Million
Q1 2021 Sep 01, 2023	BUY	$153.07 - $170.48 $76,535 - $85,240	500 Added 9.23%	5,917 $972 Million
Q4 2020 Sep 01, 2023	BUY	$137.11 - $157.38 $21,800 - $25,023	159 Added 3.02%	5,417 $853 Million
Q3 2020 Sep 01, 2023	SELL	$140.38 - $153.83 $40,850 - $44,764	-291 Reduced 5.24%	5,258 $783 Million
Q2 2020 Sep 01, 2023	SELL	$128.81 - $155.51 $2,447 - $2,954	-19 Reduced 0.34%	5,549 $780 Million
Q1 2020 Sep 01, 2023	SELL	$111.14 - $153.99 $222 - $307	-2 Reduced 0.04%	5,568 $730 Million
Q4 2019 Sep 01, 2023	SELL	$127.5 - $146.44 $28,942 - $33,241	-227 Reduced 3.92%	5,570 $813 Million
Q3 2019 Sep 01, 2023	BUY	$126.95 - $142.14 $66,267 - $74,197	522 Added 9.9%	5,797 $750 Million
Q2 2019 Sep 01, 2023	SELL	$131.15 - $144.24 $225,578 - $248,092	-1,720 Reduced 24.59%	5,275 $735 Million
Q1 2019 Aug 31, 2023	BUY	$125.72 - $139.79 $326,872 - $363,454	2,600 Added 59.16%	6,995 $978 Million
Q4 2018 Aug 31, 2023	BUY	$122.84 - $147.84 $41,028 - $49,378	334 Added 8.22%	4,395 $567 Million
Q3 2018 Aug 31, 2023	SELL	$121.58 - $142.88 $19,452 - $22,860	-160 Reduced 3.79%	4,061 $561 Million
Q2 2018 Aug 31, 2023	BUY	$119.4 - $131.76 $23,880 - $26,352	200 Added 4.97%	4,221 $512 Million
Q1 2018 Aug 31, 2023	BUY	$125.1 - $148.14 $6,505 - $7,703	52 Added 1.31%	4,021 $515 Million
Q4 2017 Aug 31, 2023	SELL	$131.22 - $143.62 $24,013 - $26,282	-183 Reduced 4.41%	3,969 $555 Million
Q3 2017 Aug 31, 2023	BUY	$129.47 - $135.38 $84,543 - $88,403	653 Added 18.66%	4,152 $540 Million
Q2 2017 Aug 31, 2023	BUY	N/A	662 Added 23.33%	3,499 $463 Million
Q1 2017 Aug 31, 2023	BUY	N/A	3 Added 0.11%	2,837 $353 Million
Q4 2016 Aug 31, 2023	BUY	N/A	129 Added 4.77%	2,834 $326 Million
Q3 2016 Aug 30, 2023	BUY	N/A	99 Added 3.8%	2,705 $320 Million
Q2 2016 Aug 30, 2023	SELL	N/A	-2,009 Reduced 43.53%	2,606 $316 Million
Q1 2016 Aug 30, 2023	BUY	N/A	4,615	4,615 $499 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrigan Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corrigan Financial, Inc. with notifications on news.

Account